, Volume 23, Issue 11–12, pp 616–625 | Cite as

Down-regulation of 14-3-3 zeta sensitizes human glioblastoma cells to apoptosis induction

  • Mansoureh HashemiEmail author
  • Alireza Zali
  • Javad Hashemi
  • Saeed Oraee-Yazdani
  • Akhtar Akbari


Strong 14-3-3 zeta protein expression plays an important role in tumorigenesis, including in the maintenance of cell growth, resistance increase, and the prevention of apoptosis. In this study, we focus on two targets: (1) the expression of 14-3-3 zeta in the different grades of human astrocytoma (II–IV), (2) suppression of 14-3-3 zeta protein expression in glioblastoma derived astrocytes by 14-3-3 zeta shRNA lentiviral particles. The tissues of human astrocytoma were provided from 30 patients (ten of each grade of astrocytoma). Control tissues were obtained from the peritumoral brain zone of those patients with glioblastoma. The protein and mRNA expression levels of each astrocytoma grade were assessed via western blotting and RT-PCR, respectively. Results indicated that 14-3-3 zeta was significantly expressed in glioblastoma multiforme (grade IV) and 14-3-3 zeta expression levels enhanced according to the increase of astrocytoma malignancy. In the cellular study for knock down of the 14-3-3 zeta protein, surgical biopsy of glioblastoma was used to isolate primary astrocyte. Astrocytes were transduced with 14-3-3 zeta shRNA or non-targeted shRNA lentiviral particles. Furthermore, reduction of the 14-3-3 zeta protein expression in the astrocytes evaluated through qRT-PCR and western blot after transduction of 14-3-3 zeta shRNA lentiviral particles. Moreover, apoptosis properties, including DNA fragmentation and ratio increase of Bax/Bcl-2 were observed in astrocytes following reduction of 14-3-3 zeta protein expression. Further observation indicated that the mitochondrial pathway through release of cytochorome c and caspase-3 activity was involved in the apoptosis induction. Hence, this study demonstrates a key role of the 14-3-3 zeta protein in tumorigenesis but also indicates that 14-3-3 zeta can be considered as a target for the astrocytoma treatment specially glioblastoma.


14-3-3 zeta protein Astrocytoma Apoptosis Knock down Oncogenesis 



This study was funded by functional neurosurgery research center, Shahid Beheshti University of medical sciences (Grant Number: 11974).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in study according to the Ethical Commission of the Shahid Beheshti University of Medical Sciences. Ethical code of study is IR.SBMU.RETECH.REC.1396.744.

Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Louis DN, Perry A, Reifenberger G, Deimling AV, Branger DF, Cavenee WK et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820CrossRefGoogle Scholar
  2. 2.
    Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–225CrossRefGoogle Scholar
  3. 3.
    Giese A, Bjerkvig R, Berens ME, Westphal M (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21:1624–1636CrossRefGoogle Scholar
  4. 4.
    Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492–507CrossRefGoogle Scholar
  5. 5.
    Cao WD, Zhang X, Zhang JN, Yang ZJ, Zhen HN, Cheng G et al (2006) Immunocytochemical detection of 14-3-3 in primary nervous system tumors. J Neuro-Oncol 77:125–130CrossRefGoogle Scholar
  6. 6.
    Van Hemert MJ, Steensma HY, van Heusden GP (2001) 14-3-3 proteins: key regulators of cell division, signaling and apoptosis. Bioessays 23:936–946CrossRefGoogle Scholar
  7. 7.
    Tzivion G, Avruch J (2002) 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J Biol Chem 277:3061–3064CrossRefGoogle Scholar
  8. 8.
    Van Heusden GP (2005) 14-3-3 proteins: regulators of numerous eukaryotic proteins. IUBMB Life 57:623–629CrossRefGoogle Scholar
  9. 9.
    Nishimura Y, Komatsu S, Ichikawa D, Nagata H, Hirajima S, Takeshita H, Kawaguchi T, Arita T et al (2013) Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma. Br J Cancer 108:1324–1331CrossRefGoogle Scholar
  10. 10.
    Neal CL, Yao J, Yang W, Zhou X, Nguyen NT, Lu J, Danes CG, Guo H et al (2009) 14-3-3 zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival. Cancer Res 69:3425–3432CrossRefGoogle Scholar
  11. 11.
    Matta A, Masui O, Siu KW, Ralhan R (2016) Identification of 14-3-3 zeta associated protein networks in oral cancer. Proteomics 16:1079–1089CrossRefGoogle Scholar
  12. 12.
    Cao L, Cao W, Zhang W, Lin H, Yang X, Zhen H, Cheng J, Dong W et al (2008) Identification of 14-3-3 protein isoforms in human astrocytoma by immunohistochemistry. Neurosci Lett 432:94–99CrossRefGoogle Scholar
  13. 13.
    Rapp UR, Fischer A, Rennefahrt UE, Hekman M, Albert S (2007) BAD association with membranes is regulated by Raf kinases and association with 14-3-3 proteins. Adv Enzyme Regul 47:281–285CrossRefGoogle Scholar
  14. 14.
    Wolvetang EJ, Pera MF, Zuckerman KS (2007) Gap junction mediated transport of shRNA between human embryonic stem cells. Biochem Biophys Res Commun 363:610–615CrossRefGoogle Scholar
  15. 15.
    Xu Y, Linde A, Larsson O, Thormeyer D, Elmen J, Wahlestedt C, Liang Z (2004) Functional comparison of single- and double-stranded siRNAs in mammalian cells. Biochem Biophys Res Commun 316:680–687CrossRefGoogle Scholar
  16. 16.
    Lemée JM, Com E, Clavreul A, Avril T, Quillien V, de Tayrac M et al (2013) Proteomic analysis of glioblastomas: what is the best brain control sample? J Proteom 24:165–173CrossRefGoogle Scholar
  17. 17.
    Hashemi M, Hadjighassem MR (2017) Preparation of primary astrocyte culture derived from human glioblastoma multiforme specimen. Bio-protocol 7:1–9Google Scholar
  18. 18.
    Hashemi M, Fallah A, Aghayan HR, Arjmand B, Yazdani N, Verdi j, Ghodsi SM, Miri SM, Hadjighassem M (2016) A new approach in gene therapy of glioblastoma multiforme: human olfactory ensheathing cells as a novel carrier for suicide gene delivery. Mol Neurobiol 53:5118–5128CrossRefGoogle Scholar
  19. 19.
    Frezza C, Cipolat S, Scorrano L (2007) Organelle isolation: functional mitochondria from mouse liver, muscle and cultured filroblasts. Nat Protoc 2:287–295CrossRefGoogle Scholar
  20. 20.
    Cao W, Yang X, Zhou J, Teng Z, Cao L, Zhang X, Fei Z (2010) Targeting 14-3-3 protein, difopein induces apoptosis of human glioma cells and suppresses tumor growth in mice. Apoptosis 15:230–241CrossRefGoogle Scholar
  21. 21.
    Yang X, Cao W, Lin H, Zhang W, Lin W, Cao L et al (2009) Isoform-specific expression of 14-3-3 proteins in human astrocytoma. J Neurol Sci 276:54–59CrossRefGoogle Scholar
  22. 22.
    Fulda S (2009) Apoptosis pathways and neuroblastoma therapy. Curr Pharm Des 15:430–435CrossRefGoogle Scholar
  23. 23.
    Fulda S (2009) Tumor resistance to apoptosis. Int J Cancer 124:511–515CrossRefGoogle Scholar
  24. 24.
    Nomura M, Shimizu S, Sugiyama T, Narita M, Ito T, Matsuda H, Tsujimoto Y (2003) 14-3-3 interacts directly with and negatively regulates pro-apoptotic Bax. J Biol Chem 278:2058–2065CrossRefGoogle Scholar
  25. 25.
    Lee YK, Hur W, Lee SW, Hong SW, Kim SW, Choi JE (2014) Knockdown of 14-3-3ζ enhances radiosensitivity and radio-induced apoptosis in CD133+ liver cancer stem cells. Exp Mol Med 46:e77CrossRefGoogle Scholar
  26. 26.
    Hannus M, Beitzinger M, Engelmann J, Weickert M, Spang R, Hannus S et al (2014) siPools: highly complex but accurately defined siRNA pools eliminate off-target effects. Nucleic Acids Res 42:8049–8061CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Functional Neurosurgery Research CenterShahid Beheshti University of Medical SciencesTehranIran
  2. 2.Department of Chemical EngineeringUniversity of LouisvilleLouisvilleUSA
  3. 3.Shohada Tajrish HospitalFunctional Neurosurgery Research CenterTehranIran

Personalised recommendations